INTUITIVE SURGICAL INC Quarterly Report for Q2 Ended Jun 30, 2023

Summary

Intuitive Surgical, Inc. (ISRG) reported robust performance in its second quarter and first half of 2023, demonstrating continued growth in revenue and procedures. Total revenue increased by 15% year-over-year for the quarter, reaching $1.76 billion, driven by strong performance in instruments and accessories, services, and systems. This growth was fueled by a significant 22% increase in da Vinci procedures globally, alongside a substantial 145% rise in Ion procedures. The company continues to expand its installed base, with da Vinci surgical systems increasing by 13% year-over-year to 8,042, and the Ion system seeing over a 100% increase in its installed base. Profitability remains strong, with operating income up 16% year-over-year for the quarter. Despite ongoing macroeconomic challenges such as inflation and supply chain pressures, ISRG has managed to mitigate these impacts, reporting that supply chain disruptions have not materially affected results to date. The company maintains a strong liquidity position with $7.13 billion in cash, cash equivalents, and investments as of June 30, 2023.

Key Highlights

• 1Total revenue grew 15% year-over-year to $1.76 billion in Q2 2023.
• 2Global da Vinci procedures increased by 22% year-over-year in Q2 2023, reaching approximately 567,000.
• 3Instruments and accessories revenue saw a 20% increase year-over-year in Q2 2023, reaching $1.08 billion.
• 4The da Vinci system installed base grew 13% year-over-year to 8,042 as of June 30, 2023.
• 5Operating income increased by 16% year-over-year in Q2 2023, reaching $463 million.
• 6The company generated strong operating cash flow, with $1.04 billion for the first six months of 2023.
• 7Cash, cash equivalents, and investments totaled $7.13 billion as of June 30, 2023, indicating a healthy liquidity position.

Frequently Asked Questions